Skip to main content

Corbus Pharmaceuticals Holdings, Inc.

CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595097

In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Corbus Pharmaceuticals Holdings, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of CRBP: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders8373−10
Shares44.5M37.5M−7.07M (−15.9%)
Value$27.2M$19.7M−$7.56M (−27.7%)

New holders (9)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to CRBP in Q1 2022
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP517,806$275.0K0.04%
FMR LLC384,604$204.0K0.00%
Kingsbury Capital Investment Advisors LLC33,800$18.0K0.02%
Mercer Global Advisors Inc32,315$17.0K0.00%
CJM Wealth Advisers, Ltd.30,465$16.2K0.01%
Virtu Financial LLC30,431$16.0K0.00%
Neuberger Berman Group LLC20,000$11.0K0.00%
Prospera Financial Services Inc1,000$1.00K0.00%
Northwestern Mutual Wealth Management Co2$00.00%

Sold out (19)

Institutions that held Corbus Pharmaceuticals Holdings, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.